Christopher Patusky, Director: United Therapeutics UTHR Sell · Filed 23/05/03

Trade details

Type: Insider sale
Amount: $726.06
Shares · price: 6 sh · $121.01 a share
Held after: 1,680 sh
Stock: United Therapeutics UTHR
Person: Christopher PatuskyDirector
Trade date: 17/10/20
Filed: 23/05/03
Days to filing: 2,021 days

Sold 0.4% of holdings

Share of holding sold: 0.4%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 17/09/20~17/11/19

Christopher Patusky's recent trades

Christopher PatuskyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$1.7M
2,910 sh
$1.7M
Filed 04/24
Traded 04/24
Christopher PatuskyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$1.7M
2,910 sh
$1.7M
Filed 04/24
Traded 04/24
Christopher PatuskyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$578.9K
1,000 sh
$578.9K
Filed 04/17
Traded 04/17
Christopher PatuskyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$578.9K
1,000 sh
$578.9K
Filed 04/17
Traded 04/17
Christopher PatuskyDirector
SellUnited Therapeutics
Sell
United Therapeutics
UTHR
$496K
1,000 sh
$496K
Filed 25/12/16
Traded 25/12/15

Christopher Patusky, Director — sold $726 of United Therapeutics UTHR · 0.4% of holdings | Whalegun